Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
A focus on PD-L1 in human melanomaPeter Hersey, Stuart GallagherJournal of Surgical Oncology|December 5, 2013
Intralesional immunotherapy for melanomaPeter Hersey, Stuart GallagherCell Cycle (Georgetown, Tex.)|February 11, 2005
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosisStuart Gallagher, Richard F Kefford, Helen RizosAdvances in Pharmacology (San Diego, Calif.)|September 11, 2012
Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitorsFritz Lai, Lei Jin, Stuart Gallagher, et al.Development (Cambridge, England)|May 18, 2018
Simulation of melanoblast displacements reveals new features of developmental migrationPascal Laurent-Gengoux, Valérie Petit, Zackie Aktary, et al.Melanoma Management|September 8, 2018
How anti-PD1 treatments are changing the management of melanomaPeter Hersey, Hojabr Kakavand, James Wilmott, et al.Pigment Cell & Melanoma Research|May 10, 2024
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatmentHsin-Yi Tseng, Sara Alavi, Stuart Gallagher, et al.Pigment Cell & Melanoma Research|February 7, 2020
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?Abdullah Al Emran, Hsin-Yi Tseng, Mikaela C Coleman, et al.International Journal of Cancer|April 7, 2020
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanomaHsin-Yi Tseng, Jan Dreyer, Abdullah Al Emran, et al.Pageof 1